API | fluoroestradiol

fluoroestradiol (Cerianna) Report issue

Small molecule Imaging Approved ^FDA

AACT PubChem

Active Ingredient History

NOW

Fluoroestradiol F-18, also known as [18F]16α-fluoroestradiol and sold under the brand name Cerianna, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging. It is an analog of estrogen and is used to detect estrogen receptor-positive breast cancer lesions. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanism of Action:
- Estrogen receptor (Ovis aries) ^UniProt
Multi-specific: Missing data
Imaging: 18-fluorine
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

Organizations (24)

Research & Development (24)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (5)

Approved Indications (1)

Breast Neoplasms (approved 2020)

Experimental Indications - Clinical Trial Phases 1-4 (5)

Breast Neoplasms (Phase 4)

Carcinoma, Ovarian Epithelial (Phase 2)

Endometriosis (Phase 2)

Pulmonary Arterial Hypertension (Phase 1)

Uterine Neoplasms (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 28
# of Trial Organizations: 24

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue